The case for immune-based approaches in biliary tract carcinoma.

about

Emerging molecular therapeutic targets for cholangiocarcinoma.Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells.New molecular and immunotherapeutic approaches in biliary cancer.

P2860

Q39227356-8CB24A4B-96A1-40DD-B5EE-AA21353D2424 Q43185882-32307FEC-F0E4-48B7-8FAB-92ED2B932753 Q54476966-BADCFC25-0BF3-41D4-B7FF-4CDC2B2C67C4

P2860

The case for immune-based approaches in biliary tract carcinoma.

Item

http://www.wikidata.org/entity/Q38833922

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The case for immune-based approaches in biliary tract carcinoma.

@en

type

Item

label

The case for immune-based approaches in biliary tract carcinoma.

@en

prefLabel

The case for immune-based approaches in biliary tract carcinoma.

@en

P1476

The case for immune-based approaches in biliary tract carcinoma.

@en

P2093

Austin G Duffy

http://www.w3.org/2001/XMLSchema#string

Oxana V Makarova-Rusher

http://www.w3.org/2001/XMLSchema#string

Tim F Greten

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer.

Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer

Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses

Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases

P304

1785-1791

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1002/HEP.28635

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27177447

http://www.w3.org/2001/XMLSchema#string

P932

5074847

http://www.w3.org/2001/XMLSchema#string

The case for immune-based approaches in biliary tract carcinoma.

about

P2860

P2860

The case for immune-based approaches in biliary tract carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932